about
Experimentally validated HERG pharmacophore models as cardiotoxicity prediction tools.Natural products modulating the hERG channel: heartaches and hope.Strychnos pseudoquina A. St. Hil.: a Brazilian medicinal plant with promising in vitro antiherpes activity.Synergistic Antiproliferative Effects of a New Cucurbitacin B Derivative and Chemotherapy Drugs on Lung Cancer Cell Line A549.In vitro testing for genotoxicity of violacein assessed by Comet and Micronucleus assays.Antiherpetic mechanism of a sulfated derivative of Agaricus brasiliensis fruiting bodies polysaccharide.Polyacetylenes from the leaves of Vernonia scorpioides (Asteraceae) and their antiproliferative and antiherpetic activities.Pharmacokinetics of hERG Channel Blocking Voacangine in Wistar Rats Applying a Validated LC-ESI-MS/MS Method.hERG Channel Blocking Ipecac Alkaloids Identified by Combined In Silico - In Vitro Screening.Evaluation of anti-HSV-2 activity of gallic acid and pentyl gallate.Ball-milled solid dispersions of BCS Class IV drugs: Impact on the dissolution rate and intestinal permeability of acyclovir.Antiherpes Activity and Skin/Mucosa Distribution of Flavonoids from Achyrocline satureioides Extract Incorporated into Topical Nanoemulsions.Preparation, characterization, and in vitro intestinal permeability evaluation of thalidomide-hydroxypropyl-β-cyclodextrin complexes.Exploration and pharmacokinetic profiling of phenylalanine based carbamates as novel substance p 1-7 analogues.Constrained H-Phe-Phe-NH2 analogues with high affinity to the substance P 1-7 binding site and with improved metabolic stability and cell permeability.Pharmacokinetic study of a carbamazepine nanoemulsion in beagle dogs.Solid dispersions enhance solubility, dissolution, and permeability of thalidomide.Enzymatic synthesis of ascorbyl ester derived from linoleic acid.In vitro antiviral activity of marine sponges collected off Brazilian coast.In Silico Workflow for the Discovery of Natural Products Activating the G Protein-Coupled Bile Acid Receptor 1.Clinical and pharmacological profile of benznidazole for treatment of Chagas diseasePharmacophore-based virtual screening as a prioritization tool to assess mechanism-based cardiotoxic effects of small organic moleculesDrug discovery for chagas disease: A viewpoint
P50
Q35229954-7AA76AEB-4565-4DF3-8467-D2328F569D11Q38684705-8D90B049-1E51-4CBA-AEF2-08620B23A59EQ38733984-749DC259-0B42-42C9-A796-2598DB2B6076Q38835173-C3162BE1-2674-4F8F-95EB-5830CE74DE83Q38875421-0A9D643F-228B-4ED7-B90A-F38D40FF87B7Q38932042-08E80C73-DB4F-4DDA-A317-229781730F66Q39111422-9BB46BC9-D4E8-4876-90A5-DB9C875D38C9Q39712625-7E3DE3A7-AC78-4AD3-BC69-87DF5BD7A8B4Q39795358-9AEF2BDB-168A-42DD-9032-E189E7D383E1Q39986233-AB07E92C-FD68-4413-9322-FCE43CE6C92DQ40869967-620CB7B7-1B66-4A00-A5C4-C7932D673356Q41144856-611877CD-AEAC-457F-9D9A-473755DD88B2Q41988429-60D00E0A-EA78-4F2B-A81F-AA8C7A6F778FQ42617933-4D6EA471-438B-44AF-93D7-FE62045E9638Q45373080-247686AB-0C6D-4A6D-AA8F-9331D4D956CAQ45980609-6299F06A-55A9-4D3F-AEE8-E489691621D3Q48913583-808EAFB5-BA46-47CF-B180-27322AE6B78FQ51135152-9435BDAE-C481-4601-B8C2-5ED10EF00FFEQ53133072-1548D1B7-F2B4-4700-97FF-BFB6E7792BF8Q55710753-1B7B7458-3B6C-483D-B837-8531C1B86062Q57912109-5F596EA2-819B-4352-8923-8FE00FD93BCFQ57912125-48046B3F-329A-44B7-B585-81EFE394AF43Q92219296-7C969417-8E16-4980-A7C6-01726239B5E1
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jadel Müller Kratz
@ast
Jadel Müller Kratz
@en
Jadel Müller Kratz
@es
Jadel Müller Kratz
@nl
Jadel Müller Kratz
@sl
type
label
Jadel Müller Kratz
@ast
Jadel Müller Kratz
@en
Jadel Müller Kratz
@es
Jadel Müller Kratz
@nl
Jadel Müller Kratz
@sl
prefLabel
Jadel Müller Kratz
@ast
Jadel Müller Kratz
@en
Jadel Müller Kratz
@es
Jadel Müller Kratz
@nl
Jadel Müller Kratz
@sl
P1053
B-8092-2011
P106
P1153
10739967500
P31
P3829
P496
0000-0002-7681-8234